Delays in breast cancer diagnosis remain a critical barrier to timely care in low-resource settings. In this study, we evaluated the diagnostic accuracy, feasibility, and clinical impact of Touch Imprint Cytology (TIC) of core needle biopsies. TIC demonstrated high sensitivity and specificity for detecting malignancy, allowing same-day breast cancer diagnosis and earlier initiation of treatment decisions without the need for repeat visits. This easy-to-perform, frugal, innovative, pragmatic solution requires minimal resources, and can easily be integrated into existing diagnostic workflows in low-resource environments.
BichooRAYadavSKMishraA, et al.Fungating breast cancer: experience in low and middle income country. Indian J Surg Oncol2020; 11: 281–286.
2.
AnandAMishraADamdeH, et al.Molecular profile and clinico-pathological characteristics of breast cancer in central India: first investigative report. Indian J Surg Oncol2022; 13: 421–425.
3.
HannaTPKingWDThibodeauS, et al.Mortality due to cancer treatment delay: systematic review and meta-analysis. Br Med J2020; 371: m4087.
4.
CarmichaelARBerresfordASamiA, et al.Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds?Breast2004; 13: 232–234.
5.
JonesLLottMFCalderCJ, et al.Imprint cytology from ultrasound-guided core biopsies: accurate and immediate diagnosis in a one-stop breast clinic. Clin Radiol2004; 59: 903–908.
6.
QureshiNABeresfordASamiS, et al.Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunt to rapid assessment breast clinics?Breast2007; 16: 81–85.
7.
KulkarniDIrvineTReyesRJ. The use of core biopsy imprint cytology in the ‘one-stop’ breast clinic. Eur J Surg Oncol2009; 35: 1037–1040.
